- Top Medical Journal Retracts Covid-19 Study Criticizing Hydroxychloroquine After Validity of Research Data Questioned
The Lancet, one of the top medical journals in the world, has retracted a study questioning the safety of treating Covid-19 with anti-malaria drug hydroxychloroquine, following controversy surrounding the research firm behind it.
The retraction officially came at the request of the study’s authors, who admitted on Thursday they could “no longer vouch for the veracity of the primary data sources.”
“We deeply apologize to you, the editors and the journal readership for any embarrassment or inconvenience that this may have caused,” the authors added.
The data used in the study appeared to show that chloroquine and hydroxychloroquine caused higher death rates in test subjects. It was cited far and wide as grounds to halt testing of both drugs in Covid-19 patients, including by the World Health Organization.